News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
687,909 Results
Type
Article (39153)
Company Profile (283)
Press Release (648473)
Section
Business (203905)
Career Advice (1996)
Deals (35371)
Drug Delivery (89)
Drug Development (80848)
Employer Resources (168)
FDA (16098)
Job Trends (14808)
News (344642)
Policy (32450)
Tag
Academia (2530)
Alliances (49185)
Alzheimer's disease (1257)
Approvals (16049)
Artificial intelligence (144)
Bankruptcy (352)
Best Places to Work (11581)
Biotechnology (200)
Breast cancer (188)
Cancer (1365)
Cardiovascular disease (110)
Career advice (1664)
Cell therapy (281)
Clinical research (64693)
Collaboration (482)
Compensation (260)
COVID-19 (2541)
C-suite (108)
Data (1389)
Diabetes (172)
Diagnostics (6170)
Earnings (84892)
Employer resources (146)
Events (110006)
Executive appointments (394)
FDA (16767)
Funding (426)
Gene therapy (195)
GLP-1 (597)
Government (4333)
Healthcare (18694)
Infectious disease (2633)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16339)
Job creations (3625)
Job search strategy (1418)
Layoffs (418)
Legal (7861)
Lung cancer (197)
Lymphoma (98)
Manufacturing (206)
Medical device (13211)
Medtech (13216)
Mergers & acquisitions (19192)
Metabolic disorders (452)
Neuroscience (1577)
NextGen Class of 2024 (6501)
Non-profit (4467)
Northern California (1693)
Obesity (258)
Opinion (183)
Patents (117)
People (56456)
Phase I (20120)
Phase II (28494)
Phase III (21237)
Pipeline (514)
Postmarket research (2560)
Preclinical (8545)
Radiopharmaceuticals (236)
Rare diseases (259)
Real estate (5890)
Regulatory (21664)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1460)
Startups (3563)
United States (15141)
Vaccines (563)
Weight loss (181)
Date
Today (31)
Last 7 days (580)
Last 30 days (2407)
Last 365 days (35198)
2024 (35002)
2023 (40076)
2022 (51173)
2021 (55711)
2020 (54088)
2019 (46542)
2018 (35019)
2017 (32111)
2016 (31481)
2015 (37552)
2014 (31321)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (195)
Asia (37267)
Australia (6087)
California (3809)
Canada (1449)
China (304)
Colorado (171)
Connecticut (176)
Europe (79827)
Florida (533)
Georgia (135)
Illinois (384)
Indiana (224)
Maryland (626)
Massachusetts (2959)
Michigan (172)
Minnesota (290)
New Jersey (1100)
New York (1080)
North Carolina (742)
Northern California (1693)
Ohio (146)
Pennsylvania (923)
South America (1091)
Southern California (1460)
Texas (547)
Utah (108)
Washington State (399)
687,909 Results for "cytokinetics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cytokinetics to Participate in December 2024 Investor Conferences
December 3, 2024
·
3 min read
Biotech Bay
Cytokinetics to Participate in June 2024 Investor Conferences
Cytokinetics, Incorporated announced that the company is scheduled to participate in the following investor conferences in June:
May 29, 2024
·
3 min read
Press Releases
Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China
December 20, 2024
·
8 min read
Press Releases
Cytokinetics to Participate in the 2024 Jefferies London Healthcare Conference
November 12, 2024
·
3 min read
Drug Development
Cytokinetics Announces Initiation of Phase 1 Study of Aficamten in Healthy Japanese Participants
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the first participants have been dosed in a Phase 1 study evaluating the pharmacokinetics, safety and tolerability of aficamten in healthy Japanese and Caucasian participants.
June 17, 2024
·
6 min read
Press Releases
Cytokinetics and Bayer Announce Exclusive Licensing Collaboration for Aficamten in Japan
November 19, 2024
·
10 min read
BioCapital
Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase Engagement in Cardiovascular Clinical Trials
Cytokinetics, Incorporated, together with The Mended Hearts, Inc. and WomenHeart: The National Coalition for Women with Heart Disease, announced the launch of ENACT: Empower, Navigate, Activate for Clinical Trials.
February 28, 2024
·
7 min read
Press Releases
Cytokinetics Reports Third Quarter 2024 Financial Results
November 7, 2024
·
18 min read
Drug Development
Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586
Cytokinetics, Incorporated announced topline data from the Phase 1 study of CK-4021586.
May 8, 2024
·
7 min read
Deals
Cytokinetics Announces Proposed Public Offering of Common Stock - May 22, 2024
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced plans to offer, subject to market and other conditions, approximately $500 million of shares of its common stock in an underwritten public offering.
May 22, 2024
·
3 min read
1 of 68,791
Next
